2003
DOI: 10.1146/annurev.polisci.6.121901.085546
|View full text |Cite
|
Sign up to set email alerts
|

THEPOLITICALECONOMY OFHEALTH INTHEUNITEDSTATES

Abstract: The United States pays a high price for its health system, and governments pay about half the costs. At the same time, the United States distinguishes itself by failing to provide health insurance for 15% of its population. In this article, I review research on the politics and economics of health to investigate three questions. Does this spending represent good value? Why does the United States spend so much on health? Finally, what technical and political challenges do policy makers face as they turn away fr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 42 publications
0
5
0
Order By: Relevance
“…Moreover, in the case of healthcare, expenditure is a particularly bad indicator of government effort (see e.g. Wilkerson, 2003).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, in the case of healthcare, expenditure is a particularly bad indicator of government effort (see e.g. Wilkerson, 2003).…”
Section: Methodsmentioning
confidence: 99%
“…Moreover, in the case of healthcare, expenditure is a particularly bad indicator of government effort (see e.g. Wilkerson, 2003). (2) Following Streeck and Mertens (2011) and Beramendi and his colleagues (2015), I expand the SI dimension by including public spending for R&D. Investing in R&D is in fact part and parcel of a SI strategy centred on human capital in a knowledge-based economy, and was among the targets of the Lisbon Strategy.…”
Section: Methodsmentioning
confidence: 99%
“…Health care is a critical factor in the quality of life of people of all nations and presents major problems for their governments. The spending worldwide of "health caredollars" continues to grow and serious questions are being asked concerning the effectiveness of the expenditure (Commonwealth Department of Health and Aged Care 1999; Lee 2004;Mehrotra et al 2003;Wagner and McCarthy 2004;Wilkerson 2003;World Health Organization 2004). The problems are multi-faceted and have many social, technological and economic dimensions.…”
Section: Introductionmentioning
confidence: 99%
“…This influence concerns many stakeholders of the medical care system and the regulatory bodies that govern that system; it also has sparked substantial international debate and has raised a number of important questions in countries around the globe. Wilkerson (2003), for example, posed the question, "Is the U.S. health care system in crisis?" (p. 328).…”
mentioning
confidence: 99%
“…The public share reflects policy differences in the organization of health care (Maarse 2006), and is one, while certainly not the only, key manifestation of the underlying differences in institutional regimes (e.g., national health services vs. national insurance systems) (Beckfield, Olafsdottir, and Sosnaud 2013;Wendt 2009). The size of the public share influences health care costs, shapes the organization of insurance, and affects how costs and risks are distributed across the population (Anderson et al 2003;Jordan 2011;Laugesen and Glied 2011;Morgan and Campbell 2011;Reinhardt, Hussey, and Anderson 2004;Tuohy, Flood, and Stabile 2004;Wilkerson 2003;Wilsford 1995). Public health care is the first or second most expensive social policy in all rich democracies.…”
mentioning
confidence: 99%